Molecular aspects of azoles-induced teratogenesis

Expert Opinion on Drug Metabolism & Toxicology
Francesca Marotta, Gian M Tiboni

Abstract

Antifungal azole compounds are widely used as antimycotics in plant, veterinary and human therapies. Their pharmacological action is based on the inhibition of the CYP450 enzyme catalyzing the synthesis of steroids required for the synthesis and integrity of fungal cell wall. Azoles are teratogenic in animal models and are under investigation for potential human developmental toxic effects. Rational approaches to prevent teratogenic effects require knowledge of the underlying mechanisms. This review highlights the current knowledge on the molecular mechanisms that are potentially involved in the teratogenic response to azoles. A comprehensive review of the literature on this subject including experimental and clinical studies. Particular attention is focused on the mechanistic role played by CYP26 family inhibition. Significant advancements have been made in the comprehension of molecular mechanisms underlying teratogenic effects mediated by azole derivatives. Increasing evidence is linking disruption of embryonic retinoic acid homeostasis as a crucial determinant of azole-mediated teratogenesis.

References

Dec 1, 1992·Journal of the American Academy of Dermatology·R B ArmstrongA A Levin
Jun 1, 1987·Southern Medical Journal·A IranmaneshC J Schleupner
Oct 22, 1970·Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology·S J YaffeS Orrenius
Jan 1, 1995·Archives of Toxicology·M PasanenO Pelkonen
Mar 1, 1995·Bulletin of Environmental Contamination and Toxicology·K Machera
Aug 1, 1994·Teratology·T H Shepard
Dec 1, 1996·American Journal of Obstetrics and Gynecology·P MastroiacovoD Fusco
Jan 1, 1997·The Annals of Pharmacotherapy·A Campomori, M Bonati
May 30, 1998·American Journal of Medical Genetics·K ChunP N Ray
Feb 25, 1999·Pharmacotherapy·S S Jick
Mar 6, 1999·Current Opinion in Microbiology·N H Georgopapadakou
Jun 4, 1999·Mechanisms of Development·K de RoosP T van der Saag
Jul 27, 1999·British Journal of Clinical Pharmacology·H T SorensenA E Czeizel
Mar 10, 2000·Clinical Pharmacokinetics·K VenkatakrishnanD J Greenblatt
Mar 16, 2000·In Vitro Cellular & Developmental Biology. Animal·E MenegolaE Giavini
May 12, 2000·Toxicology in Vitro : an International Journal Published in Association with BIBRA·A M VinggaardJ C Larsen
Sep 9, 2000·Journal of Medical Genetics·W Reardon
Sep 19, 2000·American Journal of Obstetrics and Gynecology·B Bar-OzG Koren
Oct 12, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Y YamamotoA C Ross
Aug 8, 2001·Reproductive Toxicology·E MenegolaE Giavini
Oct 24, 2001·Trends in Genetics : TIG·I Stoilov
Mar 1, 2002·British Journal of Cancer·J Van HeusdenW Wouters
Jun 11, 2002·Archives of Biochemistry and Biophysics·Yuanping WangA Catharine Ross
Nov 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Karen NiederreitherPascal Dolle
Mar 4, 2003·Environmental Health Perspectives·Jürg A ZarnJosef R Schlatter
May 20, 2003·Journal of Enzyme Inhibition and Medicinal Chemistry·Andrew J KirbyClaire Simons
May 22, 2003·Journal of Pediatric Hematology/oncology·Kelly L VanierDonna L Johnston
May 24, 2003·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·Y ChaiJ Han
May 29, 2003·Birth Defects Research. Part A, Clinical and Molecular Teratology·Elena MenegolaErminio Giavini
Jan 1, 1965·Annual Review of Pharmacology·D A KARNOFSKY
Oct 9, 2003·The Journal of Biological Chemistry·Mohammed TaimiMartin Petkovich

❮ Previous
Next ❯

Citations

Mar 3, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Sanne A B HermsenAldert H Piersma
Apr 5, 2013·Archives of Toxicology·Elena MenegolaErminio Giavini
Jul 17, 2014·Environmental Science and Pollution Research International·Bin ZhuGao-Xue Wang
Jun 6, 2012·Reproductive Toxicology·Sanne A B HermsenAldert H Piersma
Jan 29, 2011·Reproductive Toxicology·Francesca Di RenzoElena Menegola
May 31, 2013·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Stefan StinchcombeBennard van Ravenzwaay
Apr 30, 2015·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Abdel-Fattah El-ShershabyFatma Kassem
Nov 28, 2013·Critical Reviews in Toxicology·Janice E ChambersGlen Van Der Kraak
Sep 26, 2013·Toxicology Mechanisms and Methods·Abdel-Fattah El-ShershabyFatma Kassem
Dec 10, 2014·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Hequn LiBennard van Ravenzwaay
Oct 30, 2016·Reproductive Toxicology·Gian Mario Tiboni, Adalisa Ponzano
Aug 30, 2013·The New England Journal of Medicine·Ditte Mølgaard-NielsenAnders Hviid
Dec 19, 2013·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·D MarkovicA Fucic
Apr 19, 2017·International Journal of Molecular Sciences·Maria Zoupa, Kyriaki Machera
Jan 29, 2019·Journal of Applied Toxicology : JAT·Changsheng JiangGuixia Liu
Jan 1, 2021·Reproductive Toxicology·Maria Cristina BudaniGian Mario Tiboni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.